Evgeny Belilovski

Statistics

Publications

Citations

582

H-Index

Active since

2017

Affiliations

Queen Mary University of London(Current)

Grodno State Medical University

P. D. Hinduja Hospital and Medical Research Centre

University of Insubria

Université Libre de Bruxelles

Evgeny Belilovski is an author at Queen Mary University of London specializing in tuberculosis drug resistance, multidrug-resistant tuberculosis treatment, and tuberculosis control.

Publications per year

2017–2021

Publications

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Borisov Se, Keertan Dheda, Martin Enwerem et al. · European Respiratory Journal · 2017 · 302 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Borisov Se, Edvardas Danila, Andrei Maryandyshev et al. · European Respiratory Journal · 2019 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Onno W. Akkerman, Alena Aleksa, Jan‐Willem C. Alffenaar et al. · International Journal of Infectious Diseases · 2019 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

S Koirala, Borisov Se, Edvardas Danila et al. · Pulmonology · 2021 · 47 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

1–4 of 4